Using microemulsions: formulation based on knowledge of their mesostructure
Microemulsions, as thermodynamically stable mixtures of oil, water, and surfactant, are
known and have been studied for more than 70 years. However, even today there are still …
known and have been studied for more than 70 years. However, even today there are still …
Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs
P Tran, JS Park - Journal of Pharmaceutical Investigation, 2021 - Springer
Background The oral route is the most popular route for the clinical administration of drugs to
treat various diseases. Before a drug is absorbed into the blood circulation, it must undergo …
treat various diseases. Before a drug is absorbed into the blood circulation, it must undergo …
[HTML][HTML] Niosomes: a strategy toward prevention of clinically significant drug incompatibilities
HB Mohamed, SM El-Shanawany, MA Hamad… - Scientific reports, 2017 - nature.com
Drug incompatibilities are considered as one of the most critical problems in intensive care
units. In the current study, the ability of nanomaterials to prevent drug incompatibilities in …
units. In the current study, the ability of nanomaterials to prevent drug incompatibilities in …
Design and evaluation of combined atorvastatin and ezetimibe optimized self-nano emulsifying drug delivery system
AR Gardouh, AM Nasef, Y Mostafa, S Gad - Journal of Drug Delivery …, 2020 - Elsevier
The purpose was to develop, optimize and assess Self-nanoemulsifying drug delivery
system (SNEDDS) to enhance solubility and dissolution rate of the poorly-water soluble …
system (SNEDDS) to enhance solubility and dissolution rate of the poorly-water soluble …
A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin
Objective: Curcumin, the golden spice from Indian saffron, has shown chemoprotective
action against many types of cancer including breast cancer. However, poor oral …
action against many types of cancer including breast cancer. However, poor oral …
Self-emulsifying drug delivery systems and their marketed products: a review
GV Betageri - Asian Journal of Pharmaceutics (AJP), 2019 - asiapharmaceutics.info
Self-emulsifying drug delivery systems (SEDDS) are one of the proven methods to increase
solubility and bioavailability of poorly soluble drugs. SEDDS are isotropic mixtures …
solubility and bioavailability of poorly soluble drugs. SEDDS are isotropic mixtures …
Solid self-nanoemulsifying systems of olmesartan medoxomil: Formulation development, micromeritic characterization, in vitro and in vivo evaluation
S Beg, OP Katare, S Saini, B Garg, RK Khurana… - Powder technology, 2016 - Elsevier
The current studies entail development and evaluation of solid self-nanoemulsifying drug
delivery systems (S-SNEDDS) employing porous carriers for enhancing the oral …
delivery systems (S-SNEDDS) employing porous carriers for enhancing the oral …
Bioavailability enhanced clopidogrel-loaded solid SNEDDS: development and in-vitro/in-vivo characterization
E Abd-Elhakeem, MHM Teaima, GA Abdelbary… - Journal of Drug Delivery …, 2019 - Elsevier
The purpose of this study is to develop solid self-nanoemulsifying drug delivery systems (S-
SNEDDS) for oral bioavailability enhancement of Clopidogrel (CLP). CLP is an anti-platelet …
SNEDDS) for oral bioavailability enhancement of Clopidogrel (CLP). CLP is an anti-platelet …
[HTML][HTML] A solid ultra fine self-nanoemulsifying drug delivery system (S-SNEDDS) of deferasirox for improved solubility: optimization, characterization, and in vitro …
The research work was designed to develop a solid self-nanoemulsifying drug delivery
system (S-SNEDDS) of deferasirox (DFX). According to the solubility studies of DFX in …
system (S-SNEDDS) of deferasirox (DFX). According to the solubility studies of DFX in …
Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor
YG Na, JJ Byeon, M Wang, HW Huh… - International journal …, 2019 - Taylor & Francis
Background Ticagrelor (TCG) is used to inhibit platelet aggregation in patients with acute
coronary syndrome, but its poor solubility and low bioavailability limit its in vivo efficacy. The …
coronary syndrome, but its poor solubility and low bioavailability limit its in vivo efficacy. The …